SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-007830
Filing Date
2023-05-03
Accepted
2023-05-03 16:08:03
Documents
77
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pahc-20230331x10q.htm   iXBRL 10-Q 1981599
2 EX-31.1 pahc-20230331xex31d1.htm EX-31.1 8155
3 EX-31.2 pahc-20230331xex31d2.htm EX-31.2 8119
4 EX-32.1 pahc-20230331xex32d1.htm EX-32.1 3878
5 EX-32.2 pahc-20230331xex32d2.htm EX-32.2 4144
  Complete submission text file 0001558370-23-007830.txt   7849515

Data Files

Seq Description Document Type Size
6 EX-101.SCH pahc-20230331.xsd EX-101.SCH 41403
7 EX-101.CAL pahc-20230331_cal.xml EX-101.CAL 73124
8 EX-101.DEF pahc-20230331_def.xml EX-101.DEF 214179
9 EX-101.LAB pahc-20230331_lab.xml EX-101.LAB 335226
10 EX-101.PRE pahc-20230331_pre.xml EX-101.PRE 356892
71 EXTRACTED XBRL INSTANCE DOCUMENT pahc-20230331x10q_htm.xml XML 1551674
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36410 | Film No.: 23883738
SIC: 2834 Pharmaceutical Preparations